TP53 and non-small cell lung carcinoma: GSEA analysis reveals that HSPH1 is enriched in the p53 signalling pathway, DNA replication and Fanconi anaemia signalling pathway, that p53 pathway inactivation is a common event in NSCLC, and that TP53 mutations are widespread in most human cancers (28).